Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

232 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Chronic treatment of non-small-cell lung cancer cells with gefitinib leads to an epigenetic loss of epithelial properties associated with reductions in microRNA-155 and -200c.
Narita M, Shimura E, Nagasawa A, Aiuchi T, Suda Y, Hamada Y, Ikegami D, Iwasawa C, Arakawa K, Igarashi K, Kuzumaki N, Yoshioka Y, Ochiya T, Takeshima H, Ushijima T, Narita M. Narita M, et al. Among authors: nagasawa a. PLoS One. 2017 Feb 22;12(2):e0172115. doi: 10.1371/journal.pone.0172115. eCollection 2017. PLoS One. 2017. PMID: 28225782 Free PMC article.
Multiple analyses of G-protein coupled receptor (GPCR) expression in the development of gefitinib-resistance in transforming non-small-cell lung cancer.
Kuzumaki N, Suzuki A, Narita M, Hosoya T, Nagasawa A, Imai S, Yamamizu K, Morita H, Suzuki T, Okada Y, Okano HJ, Yamashita JK, Okano H, Narita M. Kuzumaki N, et al. Among authors: nagasawa a. PLoS One. 2012;7(10):e44368. doi: 10.1371/journal.pone.0044368. Epub 2012 Oct 29. PLoS One. 2012. PMID: 23144692 Free PMC article.
Correction: Multiple Analyses of G-Protein Coupled Receptor (GPCR) Expression in the Development of Gefitinib-Resistance in Transforming Non-Small-Cell Lung Cancer.
Kuzumaki N, Suzuki A, Narita M, Hosoya T, Nagasawa A, Imai S, Yamamizu K, Morita H, Suzuki T, Okada Y, Okano HJ, Yamashita JK, Okano H, Narita M. Kuzumaki N, et al. Among authors: nagasawa a. PLoS One. 2013 Aug 8;8(8):10.1371/annotation/49257f53-8cb1-431b-be64-7b410598b845. doi: 10.1371/annotation/49257f53-8cb1-431b-be64-7b410598b845. eCollection 2013. PLoS One. 2013. PMID: 29220846 Free PMC article.
Combination of a Topical Anti-Inflammatory Drug and a Moisturizer, Both with a Lamellar Structure Containing Synthetic Pseudo-Ceramides, for the Treatment of Patients with Mild-to-Moderate Atopic Dermatitis.
Okoshi K, Ito S, Matsuoka M, Kinugasa Y, Shimizu E, Tanaka K, Okada J, Nishizaka T, Nagasawa A, Seki T, Iijima M, Abe M, Nemoto O. Okoshi K, et al. Among authors: nagasawa a. Clin Cosmet Investig Dermatol. 2024 Jul 3;17:1569-1578. doi: 10.2147/CCID.S467934. eCollection 2024. Clin Cosmet Investig Dermatol. 2024. PMID: 38974707 Free PMC article.
Single-nucleotide polymorphism array and fluorescence in situ hybridization analysis to decode the cytogenetic profile of atypical partial hydatidiform moles diagnosed by short tandem repeat polymorphism analysis.
Suzuki Y, Usui H, Katayama E, Sato A, Nakamura N, Nakada E, Omoto A, Okayama J, Sato M, Nagasawa A, Hirosawa A, Shozu M, Koga K. Suzuki Y, et al. Among authors: nagasawa a. Genes Chromosomes Cancer. 2024 Feb;63(2):e23220. doi: 10.1002/gcc.23220. Genes Chromosomes Cancer. 2024. PMID: 38780072
232 results